These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 22579008)
41. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Englund G; Jacobson A; Rorsman F; Artursson P; Kindmark A; Rönnblom A Inflamm Bowel Dis; 2007 Mar; 13(3):291-7. PubMed ID: 17206689 [TBL] [Abstract][Full Text] [Related]
42. Fructose suppresses uric acid excretion to the intestinal lumen as a result of the induction of oxidative stress by NADPH oxidase activation. Kaneko C; Ogura J; Sasaki S; Okamoto K; Kobayashi M; Kuwayama K; Narumi K; Iseki K Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):559-566. PubMed ID: 27913188 [TBL] [Abstract][Full Text] [Related]
43. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells. Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687 [TBL] [Abstract][Full Text] [Related]
44. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. Sergent T; Dupont I; Jassogne C; Ribonnet L; van der Heiden E; Scippo ML; Muller M; McAlister D; Pussemier L; Larondelle Y; Schneider YJ Toxicol Lett; 2009 Feb; 184(3):159-68. PubMed ID: 19070657 [TBL] [Abstract][Full Text] [Related]
45. Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9. Tang L; Li Y; Chen WY; Zeng S; Dong LN; Peng XJ; Jiang W; Hu M; Liu ZQ Pharm Res; 2014 Apr; 31(4):847-60. PubMed ID: 24092055 [TBL] [Abstract][Full Text] [Related]
46. Reversible inhibition of efflux transporters by hydrogel microdevices. Levy ES; Samy KE; Lamson NG; Whitehead KA; Kroetz DL; Desai TA Eur J Pharm Biopharm; 2019 Dec; 145():76-84. PubMed ID: 31639417 [TBL] [Abstract][Full Text] [Related]
47. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway. Chen M; Lu X; Lu C; Shen N; Jiang Y; Chen M; Wu H Arthritis Res Ther; 2018 Feb; 20(1):20. PubMed ID: 29415757 [TBL] [Abstract][Full Text] [Related]
48. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. Collett A; Higgs NB; Sims E; Rowland M; Warhurst G J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768 [TBL] [Abstract][Full Text] [Related]
49. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides. Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243 [TBL] [Abstract][Full Text] [Related]
50. ABCG2/BCRP interaction with the sea grass Thalassia testudinum. Miguel V; Otero JA; Barrera B; Rodeiro I; Prieto JG; Merino G; Álvarez AI Drug Metab Pers Ther; 2015 Dec; 30(4):251-6. PubMed ID: 26444365 [TBL] [Abstract][Full Text] [Related]
51. Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production. He H; Buckley M; Britton B; Mu Y; Warner K; Kumar S; Cory TJ Antivir Chem Chemother; 2018; 26():2040206617745168. PubMed ID: 29343083 [TBL] [Abstract][Full Text] [Related]
52. BCRP transports dipyridamole and is inhibited by calcium channel blockers. Zhang Y; Gupta A; Wang H; Zhou L; Vethanayagam RR; Unadkat JD; Mao Q Pharm Res; 2005 Dec; 22(12):2023-34. PubMed ID: 16247709 [TBL] [Abstract][Full Text] [Related]
53. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients. Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265 [TBL] [Abstract][Full Text] [Related]
54. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701 [TBL] [Abstract][Full Text] [Related]
55. Effect of quercetin on the uptake and efflux of aristolochic acid I from Caco-2 cell monolayers. Kimura O; Fujii Y; Haraguchi K; Ohta C; Koga N; Kato Y; Endo T J Pharm Pharmacol; 2016 Jul; 68(7):883-9. PubMed ID: 27166429 [TBL] [Abstract][Full Text] [Related]
56. Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine. Zhu W; Xu H; Wang SW; Hu M AAPS J; 2010 Dec; 12(4):525-36. PubMed ID: 20582579 [TBL] [Abstract][Full Text] [Related]
57. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting. Dahan A; Amidon GL Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137 [TBL] [Abstract][Full Text] [Related]
58. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems. Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393 [TBL] [Abstract][Full Text] [Related]
59. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil. Choi MK; Song IS J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210 [TBL] [Abstract][Full Text] [Related]
60. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass. Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]